These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31512855)

  • 21. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
    Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
    Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Nitro-Thiophene-Thiosemicarbazone Derivatives Present Antitumor Activity Mediated by Apoptosis and DNA Intercalation.
    Roque Marques KM; do Desterro MR; de Arruda SM; de Araújo Neto LN; do Carmo Alves de Lima M; de Almeida SMV; da Silva ECD; de Aquino TM; da Silva-Júnior EF; de Araújo-Júnior JX; de M Silva M; de A Dantas MD; Santos JCC; Figueiredo IM; Bazin MA; Marchand P; da Silva TG; Mendonça Junior FJB
    Curr Top Med Chem; 2019; 19(13):1075-1091. PubMed ID: 31223089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure of [(η(6)-p-cymene)Ru(2-anthracen-9-ylmethylene-N-ethylhydrazinecarbothioamide)Cl]Cl; biological evaluation, topoisomerase II inhibition and reaction with DNA and human serum albumin.
    Beckford F; Thessing J; Woods J; Didion J; Gerasimchuk N; Gonzalez-Sarrias A; Seeram NP
    Metallomics; 2011 May; 3(5):491-502. PubMed ID: 21347491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison.
    Cowell IG; Ling EM; Swan RL; Brooks MLW; Austin CA
    Mol Pharmacol; 2019 Nov; 96(5):562-572. PubMed ID: 31515282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase IIα.
    Infante Lara L; Sledge A; Laradji A; Okoro CO; Osheroff N
    Bioorg Med Chem Lett; 2017 Feb; 27(3):586-589. PubMed ID: 27998679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cu(II) complexes with heterocyclic substituted thiosemicarbazones: the case of 5-formyluracil. Synthesis, characterization, x-ray structures, DNA interaction studies, and biological activity.
    Baldini M; Belicchi-Ferrari M; Bisceglie F; Pelosi G; Pinelli S; Tarasconi P
    Inorg Chem; 2003 Mar; 42(6):2049-55. PubMed ID: 12639140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HU-331 is a catalytic inhibitor of topoisomerase IIα.
    Regal KM; Mercer SL; Deweese JE
    Chem Res Toxicol; 2014 Dec; 27(12):2044-51. PubMed ID: 25409338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel indeno[1,2-b]pyridinone derivative, a DNA intercalative human topoisomerase IIα catalytic inhibitor, for caspase 3-independent anticancer activity.
    Jeon KH; Park C; Kadayat TM; Shrestha A; Lee ES; Kwon Y
    Chem Commun (Camb); 2017 Jun; 53(51):6864-6867. PubMed ID: 28604852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors.
    Park S; Hong E; Kwak SY; Jun KY; Lee ES; Kwon Y; Na Y
    Eur J Med Chem; 2016 Nov; 123():211-225. PubMed ID: 27484510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.
    Wei L; Easmon J; Nagi RK; Muegge BD; Meyer LA; Lewis JS
    J Nucl Med; 2006 Dec; 47(12):2034-41. PubMed ID: 17138747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel 4-quinoline-thiosemicarbazone derivatives: Synthesis, antiproliferative activity, in vitro and in silico biomacromolecule interaction studies and topoisomerase inhibition.
    Ribeiro AG; Almeida SMV; de Oliveira JF; Souza TRCL; Santos KLD; Albuquerque APB; Nogueira MCBL; Carvalho Junior LB; Moura RO; da Silva AC; Pereira VRA; Castro MCAB; Lima MDCA
    Eur J Med Chem; 2019 Nov; 182():111592. PubMed ID: 31421632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
    McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
    Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel nalidixic acid derivatives targeting topoisomerase II enzyme; Design, synthesis, anticancer activity and effect on cell cycle profile.
    Khalil OM; Gedawy EM; El-Malah AA; Adly ME
    Bioorg Chem; 2019 Mar; 83():262-276. PubMed ID: 30391699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.
    Infante Lara L; Fenner S; Ratcliffe S; Isidro-Llobet A; Hann M; Bax B; Osheroff N
    Nucleic Acids Res; 2018 Mar; 46(5):2218-2233. PubMed ID: 29447373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
    Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
    Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes.
    Jiang X; Fielding LA; Davis H; Carroll W; Lisic EC; Deweese JE
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
    Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
    Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalytic core of human topoisomerase IIα: insights into enzyme-DNA interactions and drug mechanism.
    Lindsey RH; Pendleton M; Ashley RE; Mercer SL; Deweese JE; Osheroff N
    Biochemistry; 2014 Oct; 53(41):6595-602. PubMed ID: 25280269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage.
    Wendorff TJ; Schmidt BH; Heslop P; Austin CA; Berger JM
    J Mol Biol; 2012 Dec; 424(3-4):109-24. PubMed ID: 22841979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.